BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35087512)

  • 1. Naringenin Regulates FKBP4/NR3C1/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell.
    Xiong H; Chen Z; Lin B; Xie B; Liu X; Chen C; Li Z; Jia Y; Wu Z; Yang M; Jia Y; Wang L; Zhou J; Meng X
    Front Immunol; 2021; 12():745111. PubMed ID: 35087512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment.
    Xiong H; Chen Z; Lin B; Chen W; Li Q; Li Y; Fang M; Wang Y; Zhang H; Lu Y; Bi A; Wu S; Jia Y; Wang X
    Mol Ther Oncolytics; 2022 Mar; 24():371-384. PubMed ID: 35118194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer.
    Mangé A; Coyaud E; Desmetz C; Laurent E; Béganton B; Coopman P; Raught B; Solassol J
    Theranostics; 2019; 9(23):7003-7015. PubMed ID: 31660083
    [No Abstract]   [Full Text] [Related]  

  • 4. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
    Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
    Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Effects of Fkbp4 and Fkbp5 on Regulation of the
    Kageyama K; Iwasaki Y; Watanuki Y; Niioka K; Daimon M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway.
    Li P; Hu J; Shi B; Tie J
    Biochem Biophys Res Commun; 2020 Oct; 531(3):320-327. PubMed ID: 32800561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway.
    Zhang L; Song L; Xu Y; Xu Y; Zheng M; Zhang P; Wang Q
    Mol Biol Rep; 2022 Apr; 49(4):2953-2961. PubMed ID: 35028860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
    Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
    Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
    Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z
    Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
    Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
    Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats.
    Kapoor R; Sirohi VK; Gupta K; Dwivedi A
    J Nutr Biochem; 2019 Aug; 70():215-226. PubMed ID: 31252288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Nrf2 promotes autophagy-dependent osteoblastic differentiation of adipose-derived mesenchymal stem cells.
    Tao J; Wang H; Zhai Y; Park H; Wang J; Ji F; Zhang Z
    Exp Cell Res; 2016 Dec; 349(2):221-229. PubMed ID: 27669641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin attenuates CCl4 -induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats.
    Esmaeili MA; Alilou M
    Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):416-22. PubMed ID: 24684352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2.
    Dong J; Li Y; Xiao H; Luo D; Zhang S; Zhu C; Jiang M; Cui M; Lu L; Fan S
    Toxicol Appl Pharmacol; 2019 Feb; 364():12-21. PubMed ID: 30529626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKBP4 integrates FKBP4/Hsp90/IKK with FKBP4/Hsp70/RelA complex to promote lung adenocarcinoma progression via IKK/NF-κB signaling.
    Zong S; Jiao Y; Liu X; Mu W; Yuan X; Qu Y; Xia Y; Liu S; Sun H; Wang L; Cui B; Liu X; Li P; Zhao Y
    Cell Death Dis; 2021 Jun; 12(6):602. PubMed ID: 34112753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Naringenin in Cigarette Smoke-Induced Damage to the Lung Based on Bioinformatic Prediction and In Vitro Analysis.
    Chen P; Xiao Z; Wu H; Wang Y; Fan W; Su W; Li P
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells.
    Wang J; Liu P; Xin S; Wang Z; Li J
    Exp Cell Res; 2017 Nov; 360(2):66-73. PubMed ID: 28782555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.